Literature DB >> 27238723

Paraoxonases-1, -2 and -3: What are their functions?

Clement E Furlong1, Judit Marsillach2, Gail P Jarvik3, Lucio G Costa4.   

Abstract

Paraoxonase-1 (PON1), an esterase/lactonase primarily associated with plasma high-density lipoprotein (HDL), was the first member of this family of enzymes to be characterized. Its name was derived from its ability to hydrolyze paraoxon, the toxic metabolite of the insecticide parathion. Related enzymes PON2 and PON3 were named from their evolutionary relationship with PON1. Mice with each PON gene knocked out were generated at UCLA and have been key for elucidating their roles in organophosphorus (OP) metabolism, cardiovascular disease, innate immunity, obesity, and cancer. PON1 status, determined with two-substrate analyses, reveals an individual's functional Q192R genotype and activity levels. The three-dimensional structure for a chimeric PON1 has been useful for understanding the structural properties of PON1 and for engineering PON1 as a catalytic scavenger of OP compounds. All three PONs hydrolyze microbial N-acyl homoserine lactone quorum sensing factors, quenching Pseudomonas aeruginosa's pathogenesis. All three PONs modulate oxidative stress and inflammation. PON2 is localized in the mitochondria and endoplasmic reticulum. PON2 has potent antioxidant properties and is found at 3- to 4-fold higher levels in females than males, providing increased protection against oxidative stress, as observed in primary cultures of neurons and astrocytes from female mice compared with male mice. The higher levels of PON2 in females may explain the lower frequency of neurological and cardiovascular diseases in females and the ability to identify males but not females with Parkinson's disease using a special PON1 status assay. Less is known about PON3; however, recent experiments with PON3 knockout mice show them to be susceptible to obesity, gallstone formation and atherosclerosis. Like PONs 1 and 2, PON3 also appears to modulate oxidative stress. It is localized in the endoplasmic reticulum, mitochondria and on HDL. Both PON2 and PON3 are upregulated in cancer, favoring tumor progression through mitochondrial protection against oxidative stress and apoptosis. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Human disease; Organophosphate; Oxidative stress; Paraoxonases

Mesh:

Substances:

Year:  2016        PMID: 27238723      PMCID: PMC5391248          DOI: 10.1016/j.cbi.2016.05.036

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  154 in total

1.  Serum esterases. I. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination.

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1953-01       Impact factor: 3.857

2.  Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?

Authors:  Gennaro Giordano; Toby B Cole; Clement E Furlong; Lucio G Costa
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-23       Impact factor: 4.219

3.  Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids.

Authors:  S T Reddy; D J Wadleigh; V Grijalva; C Ng; S Hama; A Gangopadhyay; D M Shih; A J Lusis; M Navab; A M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

Review 4.  The effects of hormones on sex differences in infection: from genes to behavior.

Authors:  S L Klein
Journal:  Neurosci Biobehav Rev       Date:  2000-08       Impact factor: 8.989

Review 5.  Pharmacological and lifestyle factors modulating serum paraoxonase-1 activity.

Authors:  Jordi Camps; Judit Marsillach; Jorge Joven
Journal:  Mini Rev Med Chem       Date:  2009-07       Impact factor: 3.862

6.  Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/MEK/SREBP-2 signalling cascade mediated by the PDGFR-beta.

Authors:  Bianca Fuhrman; Anna Gantman; Jasmin Khateeb; Nina Volkova; Sven Horke; Julia Kiyan; Inna Dumler; Michael Aviram
Journal:  Cardiovasc Res       Date:  2009-06-04       Impact factor: 10.787

7.  Serum esterases. II. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera.

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1953-01       Impact factor: 3.857

8.  Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.

Authors:  Franz Worek; Thomas Seeger; Moshe Goldsmith; Yacov Ashani; Haim Leader; Joel S Sussman; Dan Tawfik; Horst Thiermann; Timo Wille
Journal:  Arch Toxicol       Date:  2014-01-30       Impact factor: 5.153

9.  Increased macrophage cholesterol biosynthesis and decreased cellular paraoxonase 2 (PON2) expression in Delta6-desaturase knockout (6-DS KO) mice: beneficial effects of arachidonic acid.

Authors:  Mira Rosenblat; Nina Volkova; Manuel Roqueta-Rivera; Manabu T Nakamura; Michael Aviram
Journal:  Atherosclerosis       Date:  2009-12-01       Impact factor: 5.162

10.  Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning.

Authors:  Richard C Stevens; Stephanie M Suzuki; Toby B Cole; Sarah S Park; Rebecca J Richter; Clement E Furlong
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-18       Impact factor: 11.205

View more
  52 in total

Review 1.  Paraoxonases: metabolic role and pharmacological projection.

Authors:  Carlos Moya; Salvador Máñez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-06       Impact factor: 3.000

2.  The evaluation of two genetic polymorphisms of paraoxonase 1 in patients with pulmonary embolism.

Authors:  Nursah Basol; Nevin Karakus; Asli Yasemen Savas; Kayhan Karakus; İlker Kaya; Serhat Karaman; Serbulent Yigit
Journal:  J Clin Lab Anal       Date:  2018-04-22       Impact factor: 2.352

3.  The clinical and prognostic significance of paraoxonase-2 in gastric cancer patients: immunohistochemical analysis.

Authors:  Xiaohua Wang; Guifang Xu; Jingyuan Zhang; Shuaiyu Wang; Min Ji; Lei Mo; Mengxia Zhu; Jun Li; Guoren Zhou; Jianwei Lu; Cheng Chen
Journal:  Hum Cell       Date:  2019-07-23       Impact factor: 4.174

4.  Serum paraoxonase 1 activity in cats: analytical validation, reference intervals, and correlation with serum amyloid A and alpha-1-acid glycoprotein.

Authors:  Gabriele Rossi; Sara Meazzi; Alessia Giordano; Saverio Paltrinieri
Journal:  J Vet Diagn Invest       Date:  2020-08-17       Impact factor: 1.279

Review 5.  Why Great Mitotic Inhibitors Make Poor Cancer Drugs.

Authors:  Victoria C Yan; Hannah E Butterfield; Anton H Poral; Matthew J Yan; Kristine L Yang; Cong-Dat Pham; Florian L Muller
Journal:  Trends Cancer       Date:  2020-06-11

Review 6.  Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.

Authors:  Carlo Cervellati; Giuseppe Valacchi; Veronica Tisato; Giovanni Zuliani; Judit Marsillach
Journal:  Minerva Med       Date:  2018-10-11       Impact factor: 4.806

Review 7.  PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders.

Authors:  Sumit Jamwal; Jennifer K Blackburn; John D Elsworth
Journal:  Pharmacol Ther       Date:  2020-10-09       Impact factor: 12.310

8.  Differentially methylated regions (DMRs) in PON3 gene between responders and non-responders to a weight loss dietary intervention: a new tool for precision management of obesity.

Authors:  Francisca Salas-Pérez; Amanda Cuevas-Sierra; Marta Cuervo; Leticia Goni; Fermín I Milagro; J Alfredo Martínez; José Ignacio Riezu-Boj
Journal:  Epigenetics       Date:  2021-01-25       Impact factor: 4.528

Review 9.  The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases.

Authors:  Anna Wysocka; Agnieszka Zwolak
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

10.  A Catalog of Human Genes Associated With Pathozoospermia and Functional Characteristics of These Genes.

Authors:  Elena V Ignatieva; Alexander V Osadchuk; Maxim A Kleshchev; Anton G Bogomolov; Ludmila V Osadchuk
Journal:  Front Genet       Date:  2021-07-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.